GDF-15 distinguished CTEPH from controls with an AUC of 0.73 (95%CI: 0.59–0.87) and at a cut-off of 1,220 pg/ml, sensitivity and specificity were 58% and 84%, respectively (Figure 2B). This evidence concerns the gene GDF15 and chronic thromboembolic pulmonary hypertension.